Tower Research Capital (TRC)’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-157,033
| Closed | -$8.24M | – | 5652 |
|
|
2020
Q3 | $8.24M | Buy |
157,033
+142,927
| +1,013% | +$5.92M | 0.09% | 37 |
|
|
2020
Q2 | $469K | Buy |
+14,106
| New | +$449K | 0.02% | 1090 |
|
|
2019
Q4 | – | Sell |
-1,216
| Closed | -$16K | – | 4789 |
|
|
2019
Q3 | $16K | Sell |
1,216
-404
| -25% | -$4.88K | ﹤0.01% | 2650 |
|
|
2019
Q2 | $20K | Buy |
+1,620
| New | +$21.5K | ﹤0.01% | 2201 |
|
|
2018
Q3 | – | Sell |
-2,039
| Closed | -$41K | – | 4482 |
|
|
2018
Q2 | $41K | Buy |
+2,039
| New | +$43.8K | ﹤0.01% | 1956 |
|
|
2017
Q2 | – | Sell |
-1,300
| Closed | -$17K | – | 3764 |
|
|
2017
Q1 | $17K | Buy |
1,300
+1,123
| +634% | +$17.6K | ﹤0.01% | 1411 |
|
|
2016
Q4 | $3K | Buy |
177
+50
| +39% | +$660 | ﹤0.01% | 3329 |
|
|
2016
Q3 | $1K | Sell |
127
-473
| -79% | -$5.56K | ﹤0.01% | 3439 |
|
|
2016
Q2 | $6K | Buy |
600
+278
| +86% | +$2.87K | ﹤0.01% | 3314 |
|
|
2016
Q1 | $3K | Buy |
322
+221
| +219% | +$2.38K | ﹤0.01% | 3219 |
|
|
2015
Q4 | $1K | Buy |
+101
| New | +$1.69K | ﹤0.01% | 4250 |
|
|
2015
Q3 | – | Sell |
-5,070
| Closed | -$116K | – | 5093 |
|
|
2015
Q2 | $116K | Sell |
5,070
-2,012
| -28% | -$40.1K | 0.01% | 687 |
|
|
2015
Q1 | $108K | Buy |
7,082
+6,659
| +1,574% | +$86.5K | 0.01% | 822 |
|
|
2014
Q4 | $5K | Sell |
423
-553
| -57% | -$6.32K | ﹤0.01% | 2771 |
|
|
2014
Q3 | $11K | Buy |
+976
| New | +$11.1K | ﹤0.01% | 2778 |
|
|
2014
Q2 | – | Sell |
-745
| Closed | -$9K | – | 4867 |
|
|
2014
Q1 | $9K | Buy |
745
+9
| +1% | +$152 | ﹤0.01% | 2746 |
|
|
2013
Q4 | $13K | Buy |
+736
| New | +$12.4K | ﹤0.01% | 2769 |
|
|
2013
Q3 | – | Sell |
-1,223
| Closed | -$18K | – | 4973 |
|
|
2013
Q2 | $18K | Buy |
+1,223
| New | +$16.1K | ﹤0.01% | 1834 |
|
Tower Research Capital (TRC)'s MNTA Position: Q4 2020 in Review
Tower Research Capital (TRC) sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 157,033 shares — an estimated $8.24M sold.
Tower Research Capital (TRC) first reported a position in MNTA in Q2 2013 and held it in 18 quarters. The position peaked at $8.24M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.
- Tower Research Capital (TRC) reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
- Tower Research Capital (TRC) sold 157,033 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $8.24M.
- Tower Research Capital (TRC) first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 18 quarters.
- Tower Research Capital (TRC)'s Momenta Pharmaceuticals, Inc. position peaked at $8.24M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.
Based on Tower Research Capital (TRC)'s 13F filing for Q4 2020, filed 16 Feb 2021.